BioMarin to Host Third Quarter 2024 Financial Results Conference Call and Webcast on Tuesday, October 29, 2024, at 4:30pm ET

Rhea-AI Summary

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) has announced that its President and CEO, Alexander Hardy, will host a conference call and webcast on Tuesday, October 29, 2024, at 4:30 p.m. ET to discuss the company's third quarter 2024 financial results and provide a general business update. The event will be accessible via phone and webcast, with dial-in numbers provided for both U.S./Canada and international participants. A replay of the call will be available, and interested parties can access a live audio webcast through the investor section of BioMarin's website. The replay will be archived on the site for one week following the call.

SAN RAFAEL, Calif., Oct. 16, 2024 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Alexander Hardy, President and Chief Executive Officer of BioMarin, will host a conference call and webcast on Tuesday, October 29, 2024, at 4:30 p.m. ET to discuss third quarter 2024 financial results and provide a general business update.

Dial-in Number 
U.S. / Canada Dial-in Number: 888-596-4144
International Dial-in Number: 646-968-2525
Conference Call ID: 4980126

U.S. / Canada Replay Dial-in Number: 800-770-2030
International Replay Dial-in Number: 609-800-9909
Playback ID: 4980126

Interested parties may access a live audio webcast of the conference call via the investor section of the BioMarin website, https://investors.biomarin.com/. A replay of the call will be archived on the site for one week following the call.

About BioMarin
Founded in 1997, BioMarin is a global biotechnology company dedicated to transforming lives through genetic discovery. The company develops and commercializes targeted therapies that address the root cause of genetic conditions. BioMarin's unparalleled research and development capabilities have resulted in eight transformational commercial therapies for patients with rare genetic disorders. The company's distinctive approach to drug discovery has produced a diverse pipeline of commercial, clinical, and pre-clinical candidates that address a significant unmet medical need, have well-understood biology, and provide an opportunity to be first-to-market or offer a substantial benefit over existing treatment options. For additional information, please visit www.biomarin.com.

Contacts:
Investors	Media
Traci McCarty	Marni Kottle
BioMarin Pharmaceutical Inc.	BioMarin Pharmaceutical Inc.
(415) 455-7558	(650) 374-2803

View original content to download multimedia:https://www.prnewswire.com/news-releases/biomarin-to-host-third-quarter-2024-financial-results-conference-call-and-webcast-on-tuesday-october-29-2024-at-430pm-et-302277174.html

SOURCE BioMarin Pharmaceutical Inc.

FAQ

When will BioMarin (BMRN) release its Q3 2024 financial results?

BioMarin (BMRN) will release its Q3 2024 financial results on Tuesday, October 29, 2024, during a conference call and webcast scheduled for 4:30 p.m. ET.

How can investors access BioMarin's (BMRN) Q3 2024 earnings call?

Investors can access BioMarin's (BMRN) Q3 2024 earnings call via phone using the provided dial-in numbers or through a live audio webcast available on the investor section of BioMarin's website.

Who will host BioMarin's (BMRN) Q3 2024 earnings call?

Alexander Hardy, President and Chief Executive Officer of BioMarin (BMRN), will host the Q3 2024 earnings call and webcast.

Will there be a replay available for BioMarin's (BMRN) Q3 2024 earnings call?

Yes, a replay of BioMarin's (BMRN) Q3 2024 earnings call will be available. It will be archived on the company's website for one week following the call.